ArticleJournal of thoracic disease2019

Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer.

Fernando Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.